IN PERSON

OBJECTIVES: Upon completion of this activity, the participant should be able to:   (1) Identify the appropriate NCCN and ASH guidelines, (2) Recognize common presenting symptoms and understand treatment modalities for patients with leukemia.  (3) Analyze clinical trials available for leukemic patients through the Baylor Research Institute.

PLANNER/MODERATOR DISCLOSURE:  The planners have no relevant financial relationship(s) with companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

ACCREDITATION: The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

DESIGNATION:  The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ABS CC: Successful completion of this CME activity enables the learner to earn credit toward the CME requirement of the American Board of Surgery’s Continuous Certification program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting ABS credit.

For information, please contact Taylor Martinez at Taylor.Martinez@BSWHealth.org